EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridge
Article Details
Authors (31)
Christopher F. Bassil
Kerry Dillon
Gray R. Anderson
Benjamin Mayro
Kayleigh N. Askin
Peter S. Winter
Stefan Harry
Samuel Gruber
Tierney M. Hall
Jacob P. Hoj
Christian Cerda-Smith
Department of Pharmacology and Cancer Biology, Duke University School of Medicine
Haley M. Hutchinson
Department of Pharmacology and Cancer Biology, Duke University School of Medicine
Shane T. Killarney
Ava Heffernan
Caroline Teddy
Katherine R. Singleton
Li Qin
Kévin Jubien-Girard
Cécile Favreau
Guillaume Robert
Barr Tivon
Ella Livnah
Nir London
Department of Chemical and Structural Biology
Rachid Benhida
Patrick Auberger
Ann Marie Pendergast
Liron Bar-Peled
David M. Lonard
Anthony R. Martin
Alexandre Puissant
Kris C. Wood
Department of Pharmacology and Cancer Biology, Duke University School of Medicine